“Inflammasomes as a Prognostic Marker and Possible Therapeutic Target in Multiple Sclerosis: A Rapid Review of the Literature”, PPCR, vol. 9, no. 2, Sep. 2023, doi: 10.21801/ppcrj.2023.92.7.